All In Biotech

Free tool

FAERS Monitor: Lumigan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022184 or its brand name (Lumigan, Bimatoprost). Reports on generic versions are filed under their own applications.

Reports

19,414

Serious

7,523

39% of reports

Hospitalization

3,122

Death reported

798

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • treatment failure3,080
  • drug ineffective1,931
  • ocular hyperaemia951
  • eye irritation925
  • fatigue708
  • eye pain681
  • intraocular pressure increased662
  • vision blurred617
  • hypersensitivity580
  • headache574
  • off label use559
  • dyspnoea546
  • diarrhoea519
  • dizziness514
  • nausea501

Reports by year received

View as table
YearReports
2004101
200573
2006102
2007129
2008139
2009247
2010290
2011398
2012641
2013561
2014616
20151,274
20161,481
20171,423
20181,091
20191,238
20203,926
20212,062
2022781
2023847
2024678
2025743
2026573

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,034,745 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intraocular pressure increasedSignal66259.154.735,838
treatment failureSignal3,08041.840.4118,510
ocular hyperaemiaSignal95122.120.818,827
eye irritationSignal92517.716.614,344
eye painSignal68113.212.37,611
vision blurredSignal6174.94.51,907
hypersensitivitySignal5803.43.1982
drug ineffective1,9311.61.5448
dizziness5141.11.06
dyspnoea5461.01.01
headache5741.00.90
fatigue7081.00.90
diarrhoea5190.90.810
off label use5590.70.680
nausea5010.70.675

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.